New Research into Treatment for Neglected Diseases on the Way

In a hunt for treatments for diseases that claim thousands of lives every year, a non-profit group is expected to initiate a project to comb the catalogues of some of Japan's biggest drug companies

In a hunt for treatments for diseases that claim thousands of lives every year, a non-profit group is expected to initiate a project to comb the catalogues of some of Japan's biggest drug companies.

The Global Health Innovative Technology Fund (GHIT Fund), set up by the Japanese government, Japanese pharma companies and the Bill & Melinda Gates Foundation, said they were looking at a potential five-year commitment of more than $100 million to support research and development into neglected diseases.

Drug May Make Breathing Easier for Millions
An experimental drug could make millions of people suffering from smoker’s lung breathe much easier.

Chronic Obstructive Pulmonary

The project will see researchers looking through the libraries of compounds held by drug companies to see what possible treatments they contain for tuberculosis, malaria, and other illnesses that threaten hundreds of millions of people in the developing world.

The announcement was made on the sidelines of the five-yearly Tokyo International Conference on African Development (TICAD) which will see Japan welcome heads of government from up to 40 African countries.

Drug-Coated Stents � Proven to be More Effective
New research proves drug-coated stents effectively combat death, heart attack and repeat procedures . A recent study done takes a closer look at the

Japanese pharmaceuticals Eisai, Daiichi Sankyo, Shionogi, Takeda Pharmaceutical and the Institute of Microbial Chemistry (BIKAKEN), will allow the fund access to their compound libraries to identify possible therapies, a statement issued by GHIT said.

"The fund is unique in that it involves a consortium of pharmaceutical companies who initiated a partnership with government and civil society to support research and development for neglected diseases," the statement said.

Anti-Cancer Drug Restores Normal Cell Growth
An experimental anti-cancer drug has shown effectiveness in treating a resistant type of lymphoma, according to a new report. Researchers say the

"It also is the first time the Japanese government, a longtime top-funder of international aid, has made a significant commitment to developing new technologies that target diseases that are mainly a burden on poor countries," it said.

Source-AFP

Antifolate Drugs may Be Effective in Treating P Vivax Malaria
Researchers of HealthNet TPO Malaria and Leishmaniasis Control Programme in Pakistan, have revealed that antifolate drugs may be effective in treating P vivax malaria.